Age related risk of myelodysplastic syndrome and acute myeloid leukemia among breast cancer survivors
Author:
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Oncology
Link
http://link.springer.com/content/pdf/10.1007/s10549-013-2773-x.pdf
Reference39 articles.
1. Early Breast Cancer Trialists’ Collaborative Group (2012) Comparisons between different polychemotherapy regimens for early breast cancer: meta-analysis of long term outcome among 100,000 women in 123 randomized trials. Lancet 379(9814):432–444
2. Larson RA (2009) Therapy-related myeloid neoplasms. Haematologica 94(4):454–459
3. Curtis R, Boice J, Stovall M et al (1992) Risk of leukemia after chemotherapy and radiation treatment for breast cancer. N Engl J Med 326:1745–1751
4. Renella R, Verkooijen HM, Fioretta G et al (2006) Increased risk of acute myeloid leukaemia after treatment for breast cancer. The Breast 15:614–619
5. Crump M, Dongsheeng T, Shepherd L, Levine M, Pritchard K (2003) Risk of acute leukemia following epirubicin-based adjuvant chemotherapy: a report from the National Cancer Institute of Canada Clinical Trials Group. J Clinic Oncol 21:3066–3071
Cited by 15 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Acute Myeloid Leukemia Post Cytotoxic Therapy in Breast Cancer Survivors—Over 23 Years of Single Center Analysis;Journal of Clinical Medicine;2024-02-08
2. Routine clinical parameters and laboratory testing predict therapy-related myeloid neoplasms after treatment for breast cancer;Haematologica;2022-06-30
3. Maximizing Breast Cancer Therapy with Awareness of Potential Treatment-Related Blood Disorders;The Oncologist;2020-02-19
4. An emerging trend of rapid increase of leukemia but not all cancers in the aging population in the United States;Scientific Reports;2019-08-19
5. Myelodysplastic syndrome and acute myeloid leukemia after receipt of granulocyte colony‐stimulating factors in older patients with non‐Hodgkin lymphoma;Cancer;2018-12-12
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3